Results 151 to 160 of about 5,383,965 (247)

Complex emotion recognition system using basic emotions via facial expression, electroencephalogram, and electrocardiogram signals: a review. [PDF]

Front Psychol
Hassannataj Joloudari J, Maftoun M, Nakisa B, Alizadehsani R, Yadollahzadeh-Tabari M, Gaftandzhieva S.   +5 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

The prospects of targeting messenger RNA surveillance factor PELOTA for developing virus resistance in plants. [PDF]

Plant Mol Biol
Majumdar A, Babu YM, Mondal F, Sarkar M, Mazumder P, Pradhan P, Kumar R, Koeda S, Roy A.   +8 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Ligand Radicals Tune LPMO Activity in Model Complex. [PDF]

Inorg Chem
Marques Netto CGC, Pandey R, Bezerra de Castro C, Moreno L, Pereira Ferreira M, Gomes Rodrigues L, Gonçalves Guimaraes W, de Araujo-Neto JH, Conciani G, Dyer RB, Jannuzzi SAV, de Moura AF, Ferreira de Souza DH, Nascimento OR.   +13 more
europepmc   +1 more source

That Complex Complex

Gastroenterology, 1980
openaire   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

A di-nuclear μ-oxido rhenium(VI) complex: from deep purple to catalytic applications.

Dalton Trans
Doliner TA, Hartmann PE, Oberwinkler G, Belaj F, Dupé A, Boese AD, Schachner JA.   +6 more
europepmc   +1 more source

Crystallographic and computational investigation of a bent-core Schiff base Ni(ii) complex with DNA and protein binding studies. [PDF]

RSC Adv
Alia KN, Debbarma BK, Nath S, Roy S, Kennedy AR, Adhikari S, Kumar MS, Das AK, Begum S, Mohiuddin G.   +9 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source